Results 311 to 320 of about 349,498 (354)

Angiotensin-Converting Enzyme in Neurosarcoidosis

Archives of Neurology, 1987
To the Editor. —We read with great interest the article by Sethi et al in the June 1986 issue of theArchives.1We wish to point out another important aspect of neurosarcoidosis that was not discussed by the authors, namely, determination of angiotensin I—converting enzyme (ACE) levels in the cerebrospinal fluid (CSF) of patients with suspected ...
I, Rubinstein, V, Hoffstein
openaire   +2 more sources

Angiotensin converting enzyme: Substrate inhibition

Peptides, 1989
Phosphate, borate, and Tris inhibit angiotensin converting enzyme (ACE), but HEPES buffer is inert. Measurements of substrate inhibition were made in HEPES buffer at pH 7.0 and 25 degrees C and 37 degrees C. Substrate inhibition was marked and goes to completion.
J R, Schullek, I B, Wilson
openaire   +2 more sources

Angiotensin-Converting Enzyme Inhibitor Angioedema

The Journal of Emergency Medicine, 2012
*Department of Emergency Medicine, University of Michigan/St. Joseph Mercy Emergency Medicine Residency, Ann Arbor, Michigan, and †Department of Emergency Medicine, University of Michigan Health System, Ann Arbor, Michigan Reprint Address:Michaelina R. Bolton, MD, Department of Emergency Medicine, University of Michigan Health System, 1500 E.
Michaelina R, Bolton, Suzanne L, Dooley-Hash   +1 more
openaire   +2 more sources

The angiotensin converting enzyme (ACE)

The International Journal of Biochemistry & Cell Biology, 2003
Angiotensin converting enzyme 1, found widely throughout the animal kingdom, is an integral membrane bound protein whose active sites are directed to the extracellular spaces. Two isoforms are expressed in mammals, a single domain germinal isoform required for male fertility, and a double domain somatic isoform which has a key role in the renin ...
openaire   +2 more sources

Oral angiotensin-converting-enzyme inhibitors

American Journal of Health-System Pharmacy, 1997
The pharmacology, pharmacokinetics, clinical uses, adverse effects, drug interactions, dosage, cost, and therapeutic interchange of oral angiotension-converting-enzyme (ACE) inhibitors are reviewed. ACE inhibitors attenuate the formation of angiotension II and may lead to the accumulation of kinins.
openaire   +2 more sources

Angiotensin-Converting Enzyme Inhibition

Journal of Cardiovascular Pharmacology, 1985
Compelling arguments can be made for a local, intrarenal role as angiotensin's first action in phylogeny, with additional cardiovascular and endocrine responses arising later. Perhaps for that reason the vascular bed of the kidney is especially responsive to angiotensin II.
openaire   +2 more sources

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

New England Journal of Medicine, 2000
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais   +5 more
semanticscholar   +1 more source

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Journal of the American Medical Association (JAMA), 2002
C. Furberg, J. Wright, B. Davis, J. Cutler, M. Alderman, H. Black, W. Cushman, R. Grimm, L. Haywood, F. Leenen, S. Oparil, J. Probstfield, P. Whelton, C. Nwachuku, D. Gordon, M. Proschan, Paula Einhom, C. Ford, L. Piller, I. K. Dunn, D. Goff, S. Pressel, Judy Bettencourt, Barbara DeLeon, Lara M. Simpson, J. Blanton, T. Geraci, Sandra M. Walsh, C. Nelson, Mahboob Rahman, Anne Juratovac, R. Pospíšil, L. Carroll, Sheila Sullivan, J. Russo, G. Barone, Rudy Christian, S. Feldman, T. Lucente, D. Calhoun, Kimo Jenkins, Peggy McDowell, Janice Johnson, C. Kingry, J. Alzate, K. Margolis, Leslie Ann Holland-Klemme, B. Jaeger, J. Williamson, Gail T. Louis, Pamela Ragusa, A. Williard, R. L. Ferguson, J. Tanner, J. Eckfeldt, R. Crow, J. Pelosi   +56 more
semanticscholar   +1 more source

Angiotensin‐Converting Enzyme in Sarcoidosis

Acta Medica Scandinavica, 1979
ABSTRACT Using a spectrophotometric assay with l‐hippuryl‐l‐histidyl‐l‐leucine as substrate, s‐angio‐tensin‐converting enzyme (SACE) was determined in 85 sarcoidosis patients, 116 healthy controls and 150 patients with various non‐sarcoid diseases. The controls showed no sex or age variation and had SACE levels of 24.4±6.2 U/ml (mean ± 1 S.D.), giving ...
openaire   +2 more sources

Angiotensin-Converting Enzyme (ACE) Inhibitors

2015
Angiotensin converting enzyme inhibitors represent a new class of agents which were designed to retain only that unique property. Because of this inhibition, administration of these agents results in the significant reduction of elevated blood pressure of various etiologies and in the amelioration of symptoms associated with congestive heart failure ...
Daniel Thomas Ginat, Jason M. Johnson
openaire   +1 more source